Hôpital Avicenne

Bobigny 93009

2 studies enrolling now · 8 studies all time

What they study most

Atherosclerotic Cardiovascular Disease (ASCVD), Chronic Lymphocytic Leukemia (CLL), Diffuse Large B Cell Lymphoma (DLBCL), Elevated Lp(a), Follicular Lymphoma (FL), Indolent Systemic Mastocytosis, Mantle Cell Lymphoma (MCL), Marginal Zone Lymphoma (MZL), Myelodysplastic Syndromes, Non Small Cell Lung Cancer, Primary Central Nervous System Lymphoma (PCNSL), Refractory Diffuse Large B-Cell Lymphoma

Studies at this site

• A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies — Recruiting now
• DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma — Recruiting now
• A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) — Running, not enrolling
• Study to Evaluate Loncastuximab Tesirine With Rituximab Versus Immunochemotherapy in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma — Running, not enrolling
• Tamibarotene Plus Azacitidine in Participants With Newly Diagnosed RARA-positive Higher-Risk Myelodysplastic Syndrome — Stopped early
• A Study in Participants With Sarcoidosis-associated Pulmonary Hypertension (SAPH) to Assess the Efficacy and Safety of Oral Selexipag — Stopped early
• OSE2101 Versus Chemotherapy in HLA-A2 Positive Patients With Advanced NSCLC After Immune Checkpoint Inhibitor Failure — Stopped early
• Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis — Completed